[Answered] What causes the let-down reflex? a. Oxytocin b. Estrongen c. Prepartum amenorrhea d. Postpartum ...

This topic contains a solution. Click here to go to the answer

Author Question: What causes the let-down reflex? a. Oxytocin b. Estrongen c. Prepartum amenorrhea d. Postpartum ... (Read 77 times)

rl

Hero Member
Posts: 579

on: Aug 21, 2018

What causes the let-down reflex?
a. Oxytocin b. Estrongen
c. Prepartum amenorrhea d. Postpartum amenorrhea

Question 2

The digestion and absorption of nutrients occur primarily in the:
a. stomach. b. pancreas.
c. small intestine. d. large intestine.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

flexer1n1

Sr. Member
Posts: 373

Reply #1 on: Aug 21, 2018

Answer to Question 1

a

Answer to Question 2

c

rl

Member
Posts: 579

Reply 2 on: Aug 21, 2018

Thanks for the timely response, appreciate it

bigsis44

Member
Posts: 317

Reply 3 on: Yesterday

Excellent

« previous next »

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.